Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cellectis (CLLS)

  • Event
  • Aug. 01, 2022, 20:30 UTC
  • 10
  • 1 comments

(99% Neutral) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K)

Comment Full text

Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI)

  • Event
  • Aug. 01, 2022, 20:21 UTC
  • 11
  • 1 comments

(85% Positive) AERIE PHARMACEUTICALS INC (AERI) Announces Enrollment Update for trials Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Comment Full text

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • Aug. 01, 2022, 20:01 UTC
  • 9
  • 1 comments

(35% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 17:16 UTC
  • 10
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:18 UTC
  • 10
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:09 UTC
  • 10
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

Genmab (GMAB)

  • Event
  • Aug. 01, 2022, 14:42 UTC
  • 10
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX)

  • Event
  • Aug. 01, 2022, 13:17 UTC
  • 13
  • 1 comments

(85% Positive) CORTEXYME, INC. (CRTX) Announces Clinical Development Update

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Aug. 01, 2022, 13:01 UTC
  • 93
  • 0 comments

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comment Full text

EAGLE PHARMS INC (EGRX)

  • Event
  • Aug. 01, 2022, 12:31 UTC
  • 13
  • 1 comments

(99% Neutral) Eagle Pharmaceuticals, Inc. (EGRX) Announces Regulatory Update

Comment Full text
  • Previous
  • 143
  • 144
  • 145
  • 146
  • 147
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin